2021: Volume 2, Issue 5
Editorial P.1-0
Respiratory fluoroquinolones and the risk of sudden cardiac death
Author(s): Emmanuel Ameyaw
Editorial P.1-1
Percentage of residual B cells after 2 weeks of rituximab treatment predicts
Author(s): Emmanuel Ameyaw
Editorial P.1-1
Stem cell study: Cystic fibrosis patients may see personalized treatments
Author(s): Sazdani Veliki Danica
Commentary P.1-1
Association between glucocorticoids treatment and viral clearance delay in patients
Author(s): Ju Wang
Commentary P.1-1
Antibiotics for lower respiratory tract infection in children presenting
Author(s): Rennie Medina